Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)
India flag India · Delayed Price · Currency is INR
1,566.00
-45.30 (-2.81%)
Last updated: Nov 16, 2026, 3:29 PM IST

Symbiotec Pharmalab Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.250.340.670.350.350.11
Debt / EBITDA Ratio
1.251.632.671.453.020.49
Net Debt / Equity Ratio
0.230.330.640.340.350.09
Net Debt / EBITDA Ratio
1.171.592.551.412.950.42
Net Debt / FCF Ratio
-2.34-7.45-1.99-10.91-1.38-1.03
Asset Turnover
-0.520.520.630.63-
Inventory Turnover
-1.381.071.171.26-
Quick Ratio
0.610.420.460.420.580.84
Current Ratio
1.360.921.041.451.762.26
Return on Equity (ROE)
-11.19%12.65%14.97%3.85%-
Return on Assets (ROA)
-6.96%7.00%7.32%3.06%-
Return on Invested Capital (ROIC)
9.73%9.37%9.26%11.40%3.64%12.00%
Return on Capital Employed (ROCE)
12.30%14.90%14.60%14.20%5.80%17.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Buyback Yield / Dilution
-9.97%-3.71%-0.17%-1.80%--